FindCure Biosciences (ZhongShan) Co., Ltd.

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Recruiting	Early phase 1	2026-09-09	NCT07468708
The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Recruiting	Early phase 1	2026-09-04	NCT07542379
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, endocrine system disorder, malignant endocrine neoplasm, neoplasm, sarcoma, skin disorder, thyroid gland disorder, thyroid tumor	Recruiting	Early phase 1	2026-09-04	NCT07459283
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors	Advanced Malignant Solid Tumors	Recruiting	Phase 1 / Phase 2	2026-09-04	NCT06499350

Clinical trials